Female infertility
Conditions
Interventions
Raceanisodamine group:Since down regulation,raceanisodamine tablets (Hangzhou Minsheng Pharmaceutical Co., Ltd., Chinese medicine approved by H33021706,5mg / tablet) were used 5mg, orally, twice a day
control group:Since down regulation,Vitamin c tablets (Huazhong Pharmaceutical Co., Ltd., Chinese medicine approved by H42020614,0.1g / tablet) were used 0.1g, orally, twice a day, continuously to the
Sponsors
Reproductive Medicine Center,Renmin Hospital,Hubei University of Medicine,Shiyan,People's Republic of China
Eligibility
Sex/Gender
Female
Age
20 Years to 38 Years
Inclusion criteria
Inclusion criteria: ? Embryos were obtained using standard IVF-ET or intracytoplasmic sperm injection; ?During the first freeze-thaw embryo transfer cycle of patients, the endometrial preparation protocol adopted the standardized GnRH-a down regulation plus hormone replacement technology of our center; ? only used whole embryo frozen blastocysts; ? patients aged <38 years; ? voluntarily participated in the clinical trial, and was able to conduct the trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: ? Contraindication of raceanisodamine tablets: increased intracranial pressure, acute cerebral hemorrhage, glaucoma, pyloric obstruction, urinary storage, hemorrhagic disease, intestinal obstruction, reflux esophagitis, severe ulcerative colitis, severe heart failure and arrhythmia; ? Intrauterine adhesion; ?Uterine adenomyosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Embryo implantation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate; | — |
Countries
China
Contacts
Public ContactShengfang Jiang
Reproductive Medicine Center,Renmin Hospital,Hubei University of Medicine,Shiyan,People's Republic of China
Outcome results
None listed